Добавил:

Sekretar kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Книга_5850_Библиотеки_им_академика_М_И_Перельмана

.pdf

Скачиваний:

Добавлен:

30.08.2026

Размер:

49 Мб

Скачать

☆

<<< < Предыдущая 12 13 14 15 16 17 18 19 20 21 22 2324 / 5024 25 26 27 28 29 30 31 32 33 34 35 36 > Следующая >>>

218

https://t.me/medicina_free

K. Mallick and S. Banerjee

(Emblica ofcinalis) exhibited antioxidant properties in changes in the rat brain brought on by chronic stress [80]. A well-known ayurvedic supplement called Triphala, which contains the herbs, Emblica ofcinalis, Terminalia belerica, and Terminalia chebula, guards against the effects of noise stress on rats’ antioxidant and cell-mediated immune systems [106]. Holi basil, or Ocimum sanctum, is also called “Tulsi” in India. It is used in Ayurveda for its healing and life-giving properties and is regarded as one of India’s holiest plants. There are other Tulsi cultivars that are sometimes referred to as “Holy,” but the Ocimum sanctum is the genuine kind [107]. Tulsi is an upright, hairy annual herb found all over India and as high as 1800m in the Himalayas. A range of disorders can be treated using tulsi. For its impact on the central nervous system, an ethanolic extract from Ocimum sanctum leaves reduced [107]. Pentobarbital-induced reex loss in mice was delayed, and the duration and intensity of convulsions brought on by electroshock and pentylenetetrazole were reduced. By analysing the levels of plasma corticosterone in rats exposed to 30min of noise stress (100dB), the ethanolic extract of leaves from Ocimum sanctum was tested for its anti-stressor effects against acute and chronic noise stress in albino rats [107]. Ethanolic extracts of Tulsi plants (Ocimum sanctum) were used to treat animals which were exposed to acute and long-term noise stress. The results showed that the plant’s anti-stress qualities prevented the increase in plasma levels of corticosterone in these animals [107].

8 Plants Modulating Serotonergic

Systems

To support physical and mental health, Ashwagandha (Withania somnifera) having adaptogenic, antidepressant, and anxiolytic properties mediated through the serotonergic system is widely used [88]. Aloysia polystachya, sometimes referred to as griseb, is a member of the Verbenaceae family. In female rats participating in the forced swim test, the hydroalcoholic extract of its (A. polystachya) leaves at varying concentrations (50, 25, and 12.5mg/kg, i.p.) (12.5, 25, and 50 mg/kg, i.p.) demonstrated anti-depressant effects. Carvone and thujone are two bioactive compounds in A. polystachya with anti-depressant characteristics and properties that can treat serotonergic abnormalities [108]. Aniba riparia (Nees) (family, Lauraceae) contains phytoactive compounds called riparin III, showing antidepressant- like action in mice when evaluated using the Tail Suspension test (TST)

and FST (25 and 50 mg/kg, intraperitoneal) [109]. Additionally, several investigations utilizing mice and rats in the behavioral study have shown that the saponins bacopasides VI-VIII, bacopaside I, bacopaside II, and bacopa saponin C. present in B. monnieri (Brahmi) has anti-depressant properties, regulating the serotonin concentration at doses of 20 and 40mg/kg [88]. A member of the Theaceae family is the tea plant Camellia sinensis (L.) Kuntze. When tested in FST on male mice, the aqueous extract of its plants’ leaves had potent serotonin-regulating activity (antidepressant-like effect) at the dose of 100 mg/kg [88]. A member of the Zingiberaceae family is Curcuma longa, often referred to as turmeric, haldi, or Haridra in India [88]. It includes curcumin, an active phytochemical with several pharmacological benets and anti-inammatory, antioxidant, and neuroprotective effects [88]. Recent research has also shown that in TST and FST, it is a more potent anti- depressant than uoxetine [110]. The Berberidaceae family includes Berberis aristata, often known as Daruharidra or Daruhaldi. It has historically been used to treat inammation, wound healing, and skin conditions. It has other pharmacological uses, including hepatoprotective, anti-diabetic, anti-inammatory, and antioxidant. It contains berberine. This isoquinoline alkaloid is an effective anti-depressant in mice when tested using FST [88]. Root components of the Alliaceae family plant Agapanthus cam- panulatus are used to initiate conventional treatments. A type of mental disorder known as “the spirit” is reported to be treated with various parts of the plant while its extracts showed SSRI action [47]. Decoctions of the plant Boophone disticha’s bulb scales are used to calm aggressive, schizophrenic patients. Bulb infusions are consumed by traditional healers and patients in South Africa as a medication to cure mental diseases and cause hallucinations for divinatory purposes [111]. Buphanidrine and buphanamine, isolated from the Amaryllidaceae plant Boophone disticha, had an afnity for the serotonin transporter (SERT) protein [147]. Powdered leaves from the Gomphocarpus physocarpus of the asclepiadaceae family are used as sedatives and to “strengthen the physique”. Xysmalobium undulatum (L.) leaves extract showed SSRI action. In the Asphodelaceae family, plants like Gasteria croucheri were used in hysteria treatment in South Africa. Leaves of Dioscorea species (Dioscoreaceae family), Millettia grandis, Schotia brachypetala, Leonotis leonurus (Lamiaceae), Mentha aquatica L., Cinnamomum camphora (L.), and Buddleja (L.) species (Loganiaceae) have effective activity against serotonergic disorders like epilepsy, hysteria, convulsions, dispel worries and inducing sleep disorders [47].

Plants Aecting Serotonergic Neurotransmission

https://t.me/medicina_free

219

9 Serotonin Contents inHerbal Plants

extracts

In the years after its discovery, serotonin has been found in more than 37 plant families and 90 species, inuenced by species, family, and the development of the maturational stage [46]. Serotonin was rst discovered in plants in the legume Mucuna pruriens [113]. Moreover, plant serotonin has signicant variations concerning environmental factors, including wavelength, light intensity, abiotic and biotic conditions, stress, and physiological conditions [46,

113, 114]. The aerial tissues of plants appear to have good

serotonin levels in vegetative tissues [115–117]. Reproductive plant parts like owers, fruits, and nuts [118–120] are generally found to have an elevated amount

of serotonin than vegetative tissues, which have classes that vary from one tissue to another and with time, maturity stage, and even within the same tissue [121–123]. The edible tissues with high serotonin concentrations include black walnut (Juglans nigra L.) (4 46 g/g), butternut (Juglans cinerea L.) (398 90 g/g), Carya ovata (Mill.) K.Koch (shagbark) (143 23g/g), and Tomato (Solanum lycopersicum L.) 156.1–221.9g/g. In edible tissues, somewhat high amounts of serotonin is found in corn (Zea mays L.) (108.2 g/g) [124], cranberry (Vaccinium spp.) (105– 122 g/g), banana (96.9 4.3 g/g) [119], ginger (Zingiber ofcinale Ros) and coffee bean (Coffea canephora) (63.3μg/g) [115], spinach, Chinese cabbage, and cherry tomatoes also contain about 100g/g of dry weight serotonin [120] (Table1).

220

https://t.me/medicina_free

K. Mallick and S. Banerjee

[37, 126]

[37, 150]

[37, 153]

[37, 157]

[158, 159]

[160, 161]

[37, 162]

[37, 163]

[37, 165]

[37, 163]

[37, 165]

[37, 167]

[37, 169]

[37, 170]

[37, 171]

process of the brain, and controls the gut microbiota

neurotoxicity, lipid peroxidation, and neuroinammation.

Neuroprotection against toxicity, inammation, oxidative stress,

apoptosis, and depression

well as 5-HT, dopamine, and MAO levels

and neurotoxicity

and depression

degeneration, inammation, oxidative stress, and depression

damage, apoptosis, and inammation

properties.

brain against toxicity, inammation, and depression

properties

brain against toxicity, inammation, and depression

stress, depression, and inammation

Improves gut microbiota balance, cognitive health, and

neuroprotection against oxidative stress, inammation, and

neuronal death

Neuroprotection against oxidative stress, toxicity, inammation,

and anxiety

brain from toxicity and oxidative damage

indicators, and 5-HT

oxidative markers

Compound Class Pharmacological Target Pharmacological Action References

Anthocyanins Flavonoid 5-HT, gut, BDNF Anti-depressant, anti-neuroinammatory, slows the ageing

Asiaticoside Terpenoid BDNF, inammatory markers, Improves colitis, GI motility, and homeostasis while preventing

Table 1 The mechanisms of the effect of medicinal herbs on serotonergic transmission

Bacoside A Terpenoid BDNF, 5-HT receptors, and synaptic proteins Anti-depressant and anti-anxiolytic [151, 152]

Astragaloside IV Polyphenol Oxidative, apoptotic, and inammatory factors, as

Anonaine Alkaloid 5-HT Anti-depressants, sedatives, and anxiolytics [154, 155]

Catechins Flavonoid BDNF, microbes, and MAO Protection of the nervous system from oxidative stress, anxiety,

Curcumin Phenol 5-HT BDNF Protection of the nervous system from oxidative stress, apoptosis,

Carvacrol Phenol 5-HT and BDNF Gastro protective and provides neuroprotection against memory

Chrysin Flavonoid 5-HT and MAO Protection of the gut and the nervous system from oxidative

Ferulic acid Phenol 5-HT, MAOA, and BDNF Increases 5-HT levels and has antidepressant and neuroprotective

Ginkgolides B Terpenoid BDNF and serotonin Increases cognitive functions and decreases stress and anxiety [37, 164]

Hesperidin Flavonoid BDNF Controls gastrointestinal motility and prevents damage for the

Hyperforin Terpenoid MAOA, kynurenine/Trp ratio, and 5-HT Antidepressant [37, 166]

Ferulic acid Phenol 5-HT, MAO-A, and BDNF Increases 5-HT levels and has antidepressant and neuroprotective

Ginkgolides B Terpenoid BDNF and serotonin Increases cognitive functions and decreases stress and anxiety [37, 164]

Hesperidin Flavonoid BDNF Controls gastrointestinal motility and prevents damage for the

Hyperforin Terpenoid MAOA, kynurenine/Trp ratio, and 5-HT Antidepressant [37, 166]

Limonene Terpene Gut microbiome, BDNF, and melatonin Neuroprotection against inammation and oxidative stress (IBD) [37, 165]

Ellagic acid Phenol 5-HT and BDNF Memory improvement and neuroprotection against oxidative

Ginsenoside Rg5 Terpenoid BDNF and serotonin Antidepressant [37, 168]

Linalool Terpenoid Mucosal immunity, gut microbiota, inammatory

Lycopene Carotenoid BDNF, serotonin, dopamine, inammatory, and

Resveratrol Polyphenol Serotonin, SERT, and BDNF Increases 5-HT levels, prevents 5-HT reuptake, and protects the

Plants Aecting Serotonergic Neurotransmission

https://t.me/medicina_free

221

10 Geographical Distribution ofPlants

Aecting Serotonergic System

In countries like India, Japan, China, Pakistan, Thailand, and Sri Lanka, traditional medicine is widely used. Medicinal plants are found in various habitats throughout India, but tropical forests in the Eastern and Western Ghats and the Himalayas are home to about 70% of the country’s medicinal plants [125]. A large number of plants, derivatives or metabolites of plants, or extracts of traditional plants helpful for serotonergic transmission, are distributed worldwide according to their suitable climatic conditions (Table2).

11 Medicinal Plants andTheir

Mechanism ofAction onSerotonergic Transmission

Inhibition of Serotonin transporter (SERT) is the main focus because SERT transports serotonin back into the presynaptic serotonergic neuron after 5-HT release into synaptic space and reduces the serotonin level in the synaptic cleft. Various plants or their extract act as SERT inhibitors to control serotonin levels [127] (Figs.3 and 4).

Jäger, A.K etal., 2013 has shown that many plants, like Danish folk, had more MAO-A inhibiting activity than inhibiting serotonin reuptake activity [127]. The Borago ofcinalis extract examined in a functional experiment for serotonin reuptake transporter inhibition, where the extract showed promising activity. The MAO inhibition is observed in ethanolic extracts of Trigonella foenum-graecum seeds (IC50 4mg/mL), Apium graveolens leaves (IC50 5mg/mL), and water extracts of aerial parts of Calluna vulgaris (IC50 8mg/ mL). Quercetin extracted from Calluna vulgaris has also shown MAO-A inhibition [127, 128]. Plant compounds such as phenols (like jatrorrhizine) [129, 130] and alkaloids [129–

132] contain MAO-A activity. It has been demonstrated that

the phenolic substance derived from the plants Paeonia mou- tan and Primula auricular is an MAO-A inhibitor, useful in increasing serotonin levels [129]. Monoamine oxidase A inhibitory action is present in the Paeonia seeds from Primula veris and Primula elatior, thus modulating serotonergic trans- mission [127]. A piperidine derivative called piperine (1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine) preferentially inhibited MAO-A over MAO-B [129]. Eugenol inhibits human MAO-A more than MAO-B [130]. The MAO-A inhibiting activity of eugenol may be the mechanism behind its antidepressant-like effects. Acori graminei rhizoma is historically been used to treat depression [130]. Colossal plant kingdoms facilitate serotonergic transmission and regulate serotonin levels helping in the treatment of dis-

eases or symptoms caused by serotonin imbalance. From various invivo studies, it has been shown that avonoids from Hemerocallis citrina affected the serotonergic and dopaminergic systems, which modulate mood [133]. In the cerebral cortex of experimental mice, ethanol extract of Uncaria lanosa Wallich var plants could increase 5-HT and 5-HIAA [134]., Tagetes erecta L. could mimic the effects of anti- depressant medications by modulating with the serotonergic, nitrergic, and sigma receptor pathways [135], Annona cheri- mola elevated the serotonin levels in the mouse brain [136], In Curcuma longa, curcumin exerted anti-depressant effects by increasing serotonin levels [137]. Phenols of Rosmarinus ofcinalis lead to a rise in pyruvate carboxylase and tyrosine hydroxylase [138]. Bupleurum falcatum affected the serotonergic systems and confers anti-depressant effects [139], via inhibiting mouse tryptophan 2, 3-dioxygenase and the expression of its genes. Extract of H. perforatum stimulates serotonin levels and elevates mood in mice [38, 166]. Paeonia glycosides increase the hippocampal production of serotonin (5-HT) and its metabolite, 5-hydroxy indole acetic acid [141]. Monoglycosides of Cynanchum auriculatum Royle inhibited serotonin reuptake in rats [142], Hypericum perforatum stimulate serotonin levels and elevates mood in those animals [38], Sideritis species as a triple monoamine reuptake inhibitor, effectively treated various illnesses, including depression and anxiety [143], Tagetes lucida Cav. show anti-depressant effects via inuencing the serotonergic system and serotonin production [144], Fructus Akebiae extract increases extracellular 5-HT and thus induce euphoria and antidepressant like effects invivo [145], Areca catechu nut increases serotonin levels [146]. Active alkaloids of some plants of the Amaryllidaceae family has both anti- depressant and happiness-boosting properties [147], Apium graveolens increases serotonin through the MAO-A activation [127], Borago of- cinalis increase serotonin levels through altering the serotonin transporter [148], Calluna vulgaris increases serotonin levels through the MAO-A activation [148] and Trigonella foenum-graecum increased serotonin levels through the MAO-A activation [148] Table2 (Figs.3 and 4).

12 Conclusion

Numerous medicinal plants, their extract, or isolated active constituents have been shown to have pharmacological effects against serotonergic disorders like depression, anxiety, insomnia, and cognitive alterations. They have fewer side effects and are available at lower cost compared to their synthetic counterparts, thus providing promising therapeutic applications against serotonin associated psychiatric disorders.

222

https://t.me/medicina_free

serotonin contents (μg/g

Fresh Weight) References

K. Mallick and S. Banerjee

[187, 188]

19–28

Methanol 110.9±22.5 [174, 175]

leaves

Amaranthaceae Spinach leaves Methanol 34.4±2.4 [173]

Cruciferae Chinese cabbage

Methanol 251 [181]

fruit

Zygophyllaceae Leaves Methanol 18,200 [176–178]

Juglandaceae The embryo of the

Rosaceae Red Fruit Methanol 10 [189, 190]

Orissa, West Bengal, Bihar, Madhya

Asia and the Near East with Europe

Medicinal plants Geographical distribution Family Plant parts used Extraction Reaction

Spinacia oleracea Tamil Nadu, Pondicherry, Maharashtra,

Brassica rapa Jammu, Kashmir, Europe, Russia, Central

Table 2 Serotonin contents in plants

Peganum harmala Africa, the Middle East, India, Pakistan,

South America, Mexico and several other

countries

Madhya Pradesh, India Solanaceae Tomato Methanol 221.9±3.8 [179, 180]

Lycopersicon

China, China, India, Japan, Siberia

esculentum

Juglans mandshurica Western and Central Asia, especially in

Mimosa tenuiora Africa, South-East Asia, India Fabaceae Leaves Methanol 8.3 [182–184]

Musa sapientum All over the tropical world Musaceae Fruit’s peel Methanol 40–150

distributed

Prunus domestica Europe, Asia, India and Worldwide

Plants Aecting Serotonergic Neurotransmission

https://t.me/medicina_free

223

Fig. 3 Biosynthesis and metabolism of Serotonin (5-HT); reuptake of 5-HT and Serotonin syndrome caused by serotonin receptor hyper stimulation and mechanism of action of phytomolecules

224

https://t.me/medicina_free

K. Mallick and S. Banerjee

Fig. 4 Mechanism of action of Herbal Medicinal Plant to control serotonin level by inhibiting the serotonin transporter (SERT) and activity of Monoamine oxidase A enzyme which convers serotonin to HIAA

References

1. Erland LAE, Saxena PK.Beyond a neurotransmitter: the role of serotonin in plants. Neurotransmitter. 2017;4:e1538.

2. Feldman R, Myers J, Quenzer L, Cooper J, Bloom F, Roth R.The biochemical bases of neuropharma. Essent Psychopharmacol Antipsychos Mood Stab. 2002;45:133.

3. Trimble M. Molecular neuropharmacology, a foundation for clinical neuroscience. Hoboken, NJ: BMJ Publishing Group Ltd.;

2002.

4. Levy RJ.Serotonin transporter mechanisms and cardiac disease. Circulation. 2006;113(1):2–4.

5. Izzati-Zade K.The role of serotonin in the pathogenesis and clinical presentations of migraine attacks. Neurosci Behav Physiol. 2008;38(5):501–5.

6. Olivier B. Serotonin: a never-ending story. Eur J Pharmacol. 2015;753:2–18.

7. Yasin T.Parkinson's disease, subthalamic nucleus and serotonin. Front Neurosci. 2009;3:3.

8. Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM.Serotonin: a review. J Vet Pharmacol Ther. 2008;31(3):187–99.

9. Brodie BB, Shore PA.A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci. 1957;66(3):631–42.

10. Johansen K.Regional distribution of circulating blood during submersion asphyxia in the duck. Acta Physiol Scand. 1964;62:1–9.

11. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71(4):533–54.

12. Kitson SL. 5-hydroxytryptamine (5-HT) receptor ligands. Curr Pharm Des. 2007;13(25):2621–37.

13. Peroutka SJ, Howell TA. The molecular evolution of G proteincoupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology. 1994;33(3–4):319–24.

14. Derkach V, Surprenant A, North RA. 5-HT3 receptors are membrane ion channels. Nature. 1989;339(6227):706–9.

15. Lam R, Michalaak E, Swinson R.Assessment scales in depression, mania and anxiety. Boca Raton, FL: CRC; 2006.

16. Lofholm PW, Katzung BG.Rational prescribing and prescription writing. In: Basic clinical pharmacology. NewYork, NY: McGrew Hill; 2001. p.1104–12.

17. Brust P, Hesse S, Muller U, Szabo Z.Neuroimaging of the serotonin transporter: possibilities and pitfalls. Curr Psychiatr Rev. 2006;2(1):111–49.

18. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment: 2005 CCNP young investigator award paper. J Psychiatry Neurosci. 2007;32(2):86–102.

19. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C, biology. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med. 2007;34(7):865–77.

20. Kumar JD, Mann JJ.PET tracers for 5-HT1A receptors and uses thereof. Drug Discov Today. 2007;12(17–18):748–56.

21. Stockmeier CA.Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatry Res. 2003;37(5):357–73.

22. Bandelow B, Michaelis S.Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2022;17:327.

Plants Aecting Serotonergic Neurotransmission

https://t.me/medicina_free

225

23. Kessler RC, Bromet EJ.The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119.

24. Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP.Inuence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8(1):56.

25. Young SN.How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci. 2007;32(6):394.

26. Evans EA, Sullivan MA.Abuse and misuse of antidepressants. Subst Abus Rehabil. 2014;5:107.

27. Zahreddine N, Richa S.Non-antidepressant treatment of generalized anxiety disorder. Curr Clin Pharmacol. 2015;10(2):86–96.

28. Shahbazi K, Solati K, Hasanpour-Dehkordi A. comparison of hypnotherapy and standard medical treatment alone on quality of life in patients with irritable Bowel syndrome: a randomized control trial. J Clin Diagn Res. 2016;10(5):Oc01–4.

29. Bahmani M, Sarrafchi A, Shirzad H, Raeian-Kopaei M.Autism: pathophysiology and promising herbal remedies. Curr Pharm Des. 2016;22(3):277–85.

30. Asgary S, Kelishadi R, Raeian-Kopaei M, Naja S, Naja M, Sahebkar AJPc. Investigation of the lipid-modifying and antiinammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr Cardiol. 2013;34(7):1729–35.

31. Asadi-Samani M, Bagheri N, Raeian-Kopaei M, Shirzad H. Inhibition of Th1 and Th17 cells by medicinal plants and their derivatives: a systematic review. Phytother Res. 2017;31(8):1128–39.

32. Raeisi R, Heidari-Soureshjani S, Asadi-Samani M, Luther T. A systematic review of phytotherapies for newborn jaundice in Iran. Int J Pharm Sci Res. 2017;8(5):1953–8.

33. Mansouri E, Asadi-Samani M, Kooti W, Ghasemiboroon M, Ashtary-Larky D, Alamiri F, Afrisham R, Hasanzadeh NZ.Antifertility effect of hydro-alcoholic extract of fennel (Foeniculum vulgare Mill) seed in male Wistar rats. J Vet Res. 2016;60(3):357–63.

34. Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, AsadiSamani M.The role of medicinal plants in the treatment of diabetes: a systematic review. Electron Physician. 2016;8(1):1832.

35. Asadi-Samani M, Bahmani M, Raeian-Kopaei M.The chemical composition, botanical characteristic and biological activities of Borago ofcinalis: a review. Asian Pac J Trop Med. 2014;7:S22–8.

36. Shabanian S, Khalili S, Lorigooini Z, Malekpour A, HeidariSoureshjani S.The effect of vaginal cream containing ginger in users of clotrimazole vaginal cream on vaginal candidiasis. J Adv Pharm Technol Res. 2017;8(2):80.

37. Liaqat H, Parveen A, Kim SY.Neuroprotective natural products’ regulatory effects on depression via gut–brain axis targeting tryptophan. Nutrients. 2022;14(16):3270.

38. Murch S, KrishnaRaj S, Saxena P.Tryptophan is a precursor for melatonin and serotonin biosynthesis in invitro regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants. Plant Cell Rep. 2000;19(7):698–704.

39. Kang S, Kang K, Lee K, Back K.Characterization of tryptamine 5-hydroxylase and serotonin synthesis in rice plants. Plant Cell Rep. 2007;26(11):2009–15.

40. Iriti M, Faoro F. Grape phytochemicals: a bouquet of old and new nutraceuticals for human health. Med Hypotheses. 2006;67(4):833–8.

41. Akula R, Giridhar P, Ravishankar GA. Phytoserotonin. Plant Signal Behav. 2011;6(6):800–9.

42. Tanis JE, Moresco JJ, Lindquist RA, Koelle MR. Regulation of serotonin biosynthesis by the G proteins Gαo and Gαq controls serotonin signaling in Caenorhabditis elegans. Genetics. 2008;178(1):157–69.

43. Berlin J, Rügenhagen C, Dietze P, Fecker LF, Goddijn OJ, Hoge JHC.Increased production of serotonin by suspension and root cultures ofPeganum harmala transformed with a tryptophan decar-

boxylase cDNA clone from Catharanthus roseus. Transgenic Res. 1993;2(6):336–44.

44. Kang K, Kang S, Lee K, Park M, Back K.Enzymatic features of serotonin biosynthetic enzymes and serotonin biosynthesis in plants. Plant Signal Behav. 2008;3(6):389–90.

45. Khoury CK, Heider B, Castañeda-Álvarez NP, Achicanoy HA, Sosa CC, Miller RE, Scotland RW, Wood JR, Rossel G, Eserman LA. Distributions, ex situ conservation priorities, and genetic resource potential of crop wild relatives of sweetpotato [Ipomoea batatas (L.) Lam., I. series Batatas]. Front Plant Sci. 2015;6:251.

46. Erland LA, Turi CE, Saxena PK.Serotonin: an ancient molecule and an important regulator of plant processes. Biotechnol Adv. 2016;34(8):1347–61.

47. Stafford GI, Pedersen PD, Jäger AK, Van Staden J.Monoamine oxidase inhibition by southern African traditional medicinal plants. S Afr J Bot. 2007;73(3):384–90.

48. Fitzgerald LW, Kaplinsky L, Kimelberg HK.Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J Neurochem. 1990;55(6):2008–14.

49. Agrawal L, Korkutata M, Vimal SK, Yadav MK, Bhattacharyya S, Shiga T. Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut. Neuropharmacology. 2020;166:107969.

50. Marazziti D.Understanding the role of serotonin in psychiatric diseases. F1000Res. 2017;6:1.

51. Bao A-M, Swaab DF. The human hypothalamus in mood disorders: the HPA axis in the center. IBRO Rep. 2019;6:45–53.

52. Khazaeipour Z, Taheri-Otaghsara S-M, Naghdi M. Depression following spinal cord injury: its relationship to demographic and socioeconomic indicators. Top Spinal Cord Inj Rehabil. 2015;21(2):149–55.

53. Meneses A.Chapter 9—5-HT4 Receptor. In: Meneses A, editor. The role of 5-HT Systems on memory and dysfunctional memory. San Diego: Academic; 2014. p.39–43.

54. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5): 286–94.

55. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M.Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299(5603):76.

56. Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14–21.

57. Bülbring E, Lin RCY, Schoeld G. An investigation of the peristaltic reex in relation to anatomical observations. Q J Exp Physiol Cogn Med Sci. 1958;43(1):26–37.

58. Boullin DJ. Observations on the Signicance OF 5- hydroxytryptamine in relation to the peristaltic reex of the rat. Br J Pharmacol Chemother. 1964;23(1):14–33.

59. Li Z, Chalazonitis A, Huang YY, Mann JJ, Margolis KG, Yang QM, Kim DO, Côté F, Mallet J, Gershon MD. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci. 2011;31(24):8998–9009.

60. Zhang X, Gainetdinov RR, Beaulieu J-M, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KRR, Caron MG.Lossof- function mutation in tryptophan hydroxylase-2 identied in unipolar major depression. Neuron. 2005;45(1):11–6.

61. Israelyan N, Del Colle A, Li Z, Park Y, Xing A, Jacobsen JPR, Luna RA, Jensen DD, Madra M, Saurman V, Rahim R, Latorre R, Law K, Carson W, Bunnett NW, Caron MG, Margolis KG.Effects of serotonin and slow-release 5-hydroxytryptophan on gastrointestinal motility in a mouse model of depression. Gastroenterology. 2019;157(2):507–521.e504.

62. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113(504):1237–64.

226

https://t.me/medicina_free

K. Mallick and S. Banerjee

63. Cowen PJ.Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol Sci. 2008;29(9):433–6.

64. Grasby P.Imaging the neurochemical brain in health and disease. Clin Med. 2002;2(1):67.

65. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C.Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol. 2007;34(7):865–77.

66. Bhagwagar Z, Rabiner E, Sargent P, Grasby P, Cowen P.Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C] WAY-100635. J Mol Psychiatry. 2004;9(4):386–92.

67. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC.Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24(3):589–91.

68. Gracie DJ, Hamlin PJ, Ford AC.The inuence of the brain–gut axis in inammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4(8):632–42.

69. Reigstad CS, Salmonson CE, Rainey JF III, Szurszewski JH, Linden DR, Sonnenburg JL, Farrugia G, Kashyap PC. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromafn cells. FASEB J. 2015;29(4):1395.

70. Zisapel N.New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175(16):3190–9.

71. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007;187(6):361–5.

72. Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte I.The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–42.

73. Isbister GK, Buckley NA.The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol. 2005;28(5):205–14.

74. McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust. 2000;173(9): 458–61.

75. Nisijima K, Yoshino T, Yui K, Katoh S.Potent serotonin (5-HT) 2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res. 2001;890(1):23–31.

76. Husain G, Mishra D, Singh P, Rao CV, Kumar V. Ethnopharmacological review of native traditional medicinal plants for brain disorders. Pharmacog Rev. 2007;1:20–8.

77. Padma T.Ayurveda. Nature. 2005;436(7050):486.

78. Cragg GM, Newman DJ, Snader KM.Natural products in drug discovery and development. J Nat Prod. 1997;60(1):52–60.

79. Nadkarni K.Nadkarni's Indian materia medica. 1954.

80. Bhattacharya SK, Bhattacharya A, Chakrabarti A.Adaptogenic activity of Siotone, a polyherbal formulation of ayurvedic rasayanas. Indian J Exp Biol. 2000;38:119–28.

81. Ghayur MN, Jalil S, Riaz N, Yousuf S, Malik A. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties q. Biochem Biophys Res Commun. 2005;334:276–87.

82. Choudhary MI, Yousuf S, Nawaz SA, Ahmed S.Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull. 2004;52(11):1358–61.

83. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V.Systemic administration of dened extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997;30(2):181–90.

84. Bhattacharya SK, Goel RK, Kaur R, Ghosal S.Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res. 1987;1(1):32–7.

85. Ghosal S, Lal J, Srivastava R, Bhattacharya SK, Upadhyay SN, Jaiswal AK, Chattopadhyay U. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytother Res. 1989;3(5):201–6.

86. Jain S, Shukla SD, Sharma K, Bhatnagar M. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res. 2001;15(6):544–8.

87. Bhattacharya S, Bhattacharya A, Sairam K, Ghosal S.Anxiolyticantidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000;7(6):463–9.

88. Kumari R, Agrawal A, Dubey G.Role of medicinal plants with antidepressant action and its mechanism: a review. Pharma Biol Eval. 2016;3(1):70–82.

89. Russo A, Borrelli F.Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4):305–17.

90. Kishore K, Singh M. Effect of bacosides, alcoholic extract of Bacopa monniera Linn. (brahmi), on experimental amnesia in mice. Indian J Exp Biol. 2005;43:640–5.

91. Singh H, Dhawan B.Neuropsychopharmacological effects of the ayurvedic nootropic Bacopa monniera Linn.(Brahmi). Indian J Pharmacol. 1997;29(5):359.

92. Enz A, Amstutz R, Boddeke H, Gmelin G, Malanowski J.Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res. 1993;98:431–8.

93. Bhattacharya S, Kumar A, Ghosal S.Effect of Bacopa monnieri on animal models of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Res Commun Pharmacol Toxicol. 1999;4(3/4):II–1.

94. Jyoti A, Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology. 2006;27(4):451–7.

95. Vijayan V, Helen A. Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice. Phytother Res. 2007;21(4):378–81.

96. Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV.Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis. 2006;9(3):243–51.

97. Anbarasi K, Vani G, Balakrishna K, Devi CS.Effect of bacoside a on brain antioxidant status in cigarette smoke exposed rats. Life Sci. 2006;78(12):1378–84.

98. Singh H, Shanker G, Patnaik G. Neuropharmacological and anti-stress effects of bacosides: a memory enhancer. Indian J Pharmacol. 1996;28:47.

99. Simon JE.Herbs, spices, and medicinal plants: recent advances in botany, horticulture, and pharmacology, vol. 3. Phoenix: Oryx Press; 1998. p.145–73.

100. Soumyanath A, Zhong YP, Yu X, Bourdette D, Koop DR, Gold SA, Gold BG. Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro. J Pharm Pharmacol. 2005;57(9):1221–9.

101. Mohandas Rao K, Muddanna Rao S, Gurumadhva RS.Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats. Evid Based Complement Alternat Med. 2006;3(3):349–57.

102. Shaughnessy F.Ease anxiety with shankhpushpi: ayurvedic doctors prefer this mood-soother over kava-kava–herb brief. Nat Health Sept. 2002:1.

103. Satyavati G, Raina M, Sharma M.Medicinal plants of India, vol.

1976. New Delhi: Indian Council of Medical Research; 1976. p.201–6.

104. Suresh K, Vasudevan DM.Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by

Plants Aecting Serotonergic Neurotransmission

https://t.me/medicina_free

227

Phyllanthus emblica, a new immunomodulator. Ethnopharmacol. 1994;44(1):55–60.

105. Dhote BS, Singh GK, Chauhan R.Effect of immuplus (an Herbal Immunomodulator) on paraspecic immune responses in chicks. J Immunol Immunopathol. 2008;10:36–41.

106. Srikumar R, Parthasarathy NJ, Manikandan S, Narayanan GS, Sheeladevi R.Effect of Triphala on oxidative stress and on cellmediated immune response against noise stress in rats. Mol Cell Biochem. 2006;283:67–74.

107. Cohen MM. Tulsi—Ocimum sanctum: a herb for all reasons. Ayurveda Integr Med. 2014;5(4):251–9.

108. Mora S, Díaz-Véliz G, Millán R, Lungenstrass H, Quirós S, CotoMorales T, Hellión-Ibarrola M.Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacol Biochem Behav. 2005;82(2):373–8.

109. Sousa F, Melo C, Monteiro A, Lima V, Gutierrez S, Pereira B, Barbosa-Filho J, Vasconcelos S, Fonteles M, Viana G.Antianxiety and antidepressant effects of riparin III from Aniba riparia (Nees) Mez (Lauraceae) in mice. Pharmacol Biochem Behav. 2004;78(1):27–33.

110. Kulkarni S, Dhir A, Akula KKJT.Potentials of curcumin as an antidepressant. Sci World J. 2009;9:1233–41.

111. Van Wyk B-E, Gericke N.People's plants: a guide to useful plants of Southern Africa. Pretoria: Briza Publications; 2000.

112. Sandager M, Nielsen ND, Stafford GI, van Staden J, Jäger AK.Alkaloids from Boophane disticha with afnity to the serotonin transporter in rat brain. J Ethnopharmacol. 2005;98(3):367–70.

113. Ramakrishna A, Giridhar P, Ravishankar GA.Phytoserotonin: a review. Plant Signal Behav. 2011;6(6):800.

114. Reynolds JD, Daniel T, Weekley LB. The effect of light quality on 5-hydroxyindole metabolism in leaves of Sedum morganianum (Crassulaceae). Biochem Physiol Panz. 1985;180(5):345–51.

115. Engström K, Lundgren L, Samuelsson G.Bioassay-guided isolation of serotonin from fruits of Solanum tuberosum L.Acta Pharm Nord. 1992;4(2):91–2.

116. Turi CE, Murch SJ.Targeted and untargeted phytochemistry of Ligusticum canbyi: indoleamines, phthalides, antioxidant potential, and use of metabolomics as a hypothesis-generating technique for compound discovery. Planta Med. 2013;79(14):1370–9.

117. Ramakrishna A, Giridhar P, Sankar KU, Ravishankar GA.Endogenous proles of indoleamines: serotonin and melatonin in different tissues of Coffea canephora P ex Fr. as analyzed by HPLC and LC-MS-ESI.Acta Physiol Plant. 2012;34(1):393–6.

118. Große W, Artigas F. Incorporation of 15N-ammonia into serotonin in cotyledons of maturing walnuts. Z Naturforsch. 1983;38(11–12):1057–8.

119. Lavizzari T, Veciana-Nogués MT, Bover-Cid S, Mariné-Font A, Vidal-Carou MC.Improved method for the determination of biogenic amines and polyamines in vegetable products by ionpair high-performance liquid chromatography. J Chromatogr A. 2006;1129(1):67–72.

120. Ly D, Kang K, Choi J-Y, Ishihara A, Back K, Lee S-G.HPLC analysis of serotonin, tryptamine, tyramine, and the hydroxycinnamic acid amides of serotonin and tyramine in food vegetables. J Med Food. 2008;11(2):385–9.

121. Udenfriend S, Lovenberg W, Sjoerdsma A.Physiologically active amines in common fruits and vegetables. Arch Biochem Biophys. 1959;85(2):487–90.

122. Adão RC, Glória MBA. Bioactive amines and carbohydrate changes during ripening ofPrata'banana (Musa acuminata× M. balbisiana). Food Chem. 2005;90(4):705–11.

123. Gloria MBA, Adão RC.Effect of gamma radiation on the ripening and levels of bioactive amines in bananas cv. Prata Radiat Phys Chem. 2013;87:97–103.

124. Badria FA.Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants. J Med Food. 2002;5(3):153–7.

125. Rasool A, Bhat KM, Sheikh AA, Jan A, Hassan S. Medicinal plants: role, distribution and future. Pharmacogn Phytochem. 2020;9(2):2111–4.

126. Wignall VR, Arscott NA, Nudds HE, Squire A, Green TO, Ratnieks FLW.Thug life: bramble (Rubus fruticosus L. agg.) is a valuable foraging resource for honeybees and diverse owervisiting insects. Insect Conserv Divers. 2020;13(6):543–57.

127. Jäger AK, Gauguin B, Andersen J, Adsersen A, Gudiksen L. Screening of plants used in Danish folk medicine to treat depression and anxiety for afnity to the serotonin transporter and inhibition of MAO-A.Ethnopharmacol. 2013;145(3):822–5.

128. Saaby L, Rasmussen HB, Jäger AK.MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J Ethnopharmacol. 2009;121(1):178–81.

129. Kong L, Cheng CH, Tan R. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol. 2004;91(2–3):351–5.

130. Tao G, Irie Y, Li D-J, Keung WM.Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity. Bioorg Med Chem. 2005;13(15):4777–88.

131. Lee SA, Hong SS, Han XH, Hwang JS, Oh GJ, Lee KS, Lee MK, Hwang BY, Ro JS.Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull. 2005;53(7):832–5.

132. Herraiz T, Chaparro C.Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee. Life Sci. 2006;78(8):795–802.

133. Du B, Tang X, Liu F, Zhang C, Zhao G, Ren F, Leng X. Antidepressant-like effects of the hydroalcoholic extracts of Hemerocallis citrina and its potential active components. BMC Complement Altern Med. 2014;14(1):1–11.

134. Hsu L-C, Ko Y-J, Cheng H-Y, Chang C-W, Lin Y-C, Cheng Y-H, Hsieh M-T, Peng WH.Antidepressant-like activity of the ethanolic extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the forced swimming test and in the tail suspension test in mice. Evid Based Complement Alternat Med. 2012;2012:497302.

135. Khulbe A, Pandey S, Sah SP.Antidepressant-like action of the hydromethanolic ower extract of Tagetes erecta L. in mice and its possible mechanism of action. Indian J Pharmacol. 2013;45(4):386.

136. Martínez-Vázquez M, Estrada-Reyes R, Escalona AA, Velázquez IL, Martínez-Mota L, Moreno J, Heinze G.Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice. J Ethnopharmacol. 2012;139(1):164–70.

137. Kulkarni S, Akula KK, Deshpande J.Evaluation of antidepressantlike activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair. Pharmacology. 2012;89(1–2):83–90.

138. Sasaki K, El Omri A, Kondo S, Han J, Isoda H.Rosmarinus ofcinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav Brain Res. 2013;238:86–94.

139. Kwon S, Lee B, Kim M, Lee H, Park H-J, Hahm D-H. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):265–70.

140. Bano S, Ara I, Saboohi K, Moattar T, Chaoudhry B. St. John's Wort increases brain serotonin synthesis by inhibiting hepatic tryptophan 2, 3 dioxygenase activity and its gene expression in stressed rats. Pak J Pharm Sci. 2014;27:1427.

141. Qiu F, Zhong X, Mao Q, Huang Z.The antidepressant-like effects of paeoniorin in mouse models. Exp Ther Med. 2013;5(4):1113–6.

142. Ji C-X, Li X-Y, Jia S-B, Liu L-L, Ge Y-C, Yang Q-X, Zhang J-J.The antidepressant effect of Cynanchum auriculatum in mice. Pharm Biol. 2012;50(9):1067–72.

<<< < Предыдущая 12 13 14 15 16 17 18 19 20 21 22 2324 / 5024 25 26 27 28 29 30 31 32 33 34 35 36 > Следующая >>>

Соседние файлы в папке Библиотека им академика М.И. Перельмана

#
30.08.202652 Мб0Книга_5846_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202652 Мб0Книга_5847_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202650 Мб0Книга_5848_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202649 Мб0Книга_5849_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202675 Мб0Книга_585_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202649 Мб0Книга_5850_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202648 Мб0Книга_5851_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202647 Мб0Книга_5852_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202646 Мб0Книга_5853_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202645 Мб0Книга_5854_Библиотеки_им_академика_М_И_Перельмана.pdf
#
30.08.202645 Мб0Книга_5855_Библиотеки_им_академика_М_И_Перельмана.pdf